LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1–TINCR-USP20-PD-L1 axisQin Wang(Harbin Medical University), Shouping Xu(Harbin Medical University)Cell Death and DiseaseFebruary 1, 202310.1038/s41419-023-05609-2Cited by 58SaveCiteExport RISWatch citationsRelated PapersAi-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer|Molecular Cancer|2019|129LncRNA TINCR favors tumorigenesis via STAT3–TINCR–EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer|Cell Death and Disease|2021|44